Regencell stated in an October SEC filing that it may be required to curtail or discontinue its operations in the future. ・In ...

Niagen Bioscience continues to see improving demand for Tru Niagen, strengthening cash generation, and a debt-free balance ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Aadi Bioscience, Inc. (AADI) is a stock that can certainly grab the attention of ...

Harvard Bioscience is seeing strong order growth for its improved product portfolio. Harvard Bioscience has strong expected earnings growth for 2023 and 2024. The stock is attractively valued and ...

An announcement from Daré Bioscience ( ($DARE) ) is now available. On January 6, 2026, Daré Bioscience, Inc. made an updated corporate ...

Invo reports $1.38 million in quarterly sales, representing a 396.15% increase over sales of $278,140 from the same period last year. The company says it remains on-track with its goal of reaching ...

As investors, we look for growing companies that can produce returns. Having said that, Harvard Bioscience stock looks ready for a run following yet another earnings beat. Will HBIO stock continue to ...

Provides Daré access to capital at Daré’s discretion with any proceeds available to help fund portfolio advancement, such as the Phase 3 program for Sildenafil Cream, 3.6%, a potential ...

BLOOMFIELD HILLS, Mich.--(BUSINESS WIRE)--Zivo Bioscience, Inc. (NASDAQ: ZIVO), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates ...

Shares of INVO Bioscience (NASDAQ:INVO) surged more than 75% in pre-market trading on Tuesday, following an announcement late Monday night that it will expand commercialization of its infertility ...